Seek Returns

IQV vs. QGEN: IQVIA vs. Qiagen Stock Comparison

How do IQVIA (IQV) and Qiagen (QGEN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

IQVIA (IQV) and Qiagen (QGEN) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Company profile comparison for IQVIA (IQV) and Qiagen (QGEN)
Profile ItemIQVQGEN
NameIQVIA Holdings Inc.Qiagen N.V.
Country/RegionUnited StatesNetherlands
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization44.80 billion USD10.39 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateMay 9, 2013June 28, 1996
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

IQV
QGEN
GSPC
Loading price history…
IQVIA (IQV) vs. Qiagen (QGEN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for IQVIA (IQV) and Qiagen (QGEN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for IQVIA (IQV) and Qiagen (QGEN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for IQVIA (IQV) and Qiagen (QGEN)
MetricIQVQGEN
Total Return (1Y)32.11%17.09%
Total Return (3Y, Annualized)13.15%10.44%
Total Return (5Y, Annualized)2.00%-0.72%

Risk Profile

Drawdown History

IQV
QGEN
GSPC
Loading price history…
IQVIA (IQV) vs. Qiagen (QGEN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for IQVIA (IQV) and Qiagen (QGEN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for IQVIA (IQV) and Qiagen (QGEN)
MetricIQVQGEN
Volatility (1Y, Annualized)40.77%35.52%
Beta (5Y)1.140.56
Max Drawdown (5Y)-51.52%-41.97%
Avg. Volume (3M)1.40M3.68M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
IQV and QGEN are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for IQVIA (IQV) and Qiagen (QGEN)
MetricIQVQGEN
Sharpe Ratio (1Y)0.680.36
Sortino Ratio (1Y)1.030.60

Profitability

ROE (TTM)

Both IQVIA (IQV) at 21.39% and Qiagen (QGEN) at 10.81% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.39%

Max
109.18%
IQV
21.39%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

10.81%

Max
109.18%
QGEN
10.81%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

Qiagen (QGEN) at 18.20% keeps the most of each sales dollar — above its industry’s net margin range — and IQVIA (IQV) at 8.05% also retains a top-quartile share.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.05%

Max
18.05%
IQV
8.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.20%

QGEN
18.20%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Qiagen (QGEN) at 27.75% operates in the top operating margin quartile, ahead of IQVIA (IQV) at 13.73%, which runs around its industry’s norm.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.73%

Max
83.12%
Q3
14.77%
IQV
13.73%
Median
0.00%
Q1
-78.82%
Min
-207.40%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.75%

Max
83.12%
QGEN
27.75%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for IQVIA (IQV) and Qiagen (QGEN)
MetricIQVQGEN
ROE (TTM)21.39%10.81%
ROA (TTM)5.08%5.68%
Net Margin (TTM)8.05%18.20%
Operating Margin (TTM)13.73%27.75%
Gross Margin (TTM)33.07%67.06%

Growth

Revenue Growth

Both IQVIA (IQV) at 5.87% and Qiagen (QGEN) at 5.65% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Qiagen (QGEN) at 409.76% clears its industry range for EPS growth, a much stronger earnings trajectory than IQVIA (IQV) at 4.67%, which is closer to a typical peer reading.

Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for IQVIA (IQV) and Qiagen (QGEN)
MetricIQVQGEN
Revenue Growth (YoY)5.87%5.65%
Revenue Growth (3Y CAGR)4.21%-0.81%
EPS Growth (YoY)4.67%409.76%
EPS Growth (3Y CAGR)11.08%-0.19%

Financial Strength

Current Ratio (MRQ)

Qiagen (QGEN) at 2.63 keeps current ratio within its industry’s typical mid-range, while IQVIA (IQV) at 0.83 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for IQV.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.83

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
IQV
0.83
Min
0.10

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.63

Max
25.13
Q3
12.13
Median
5.52
QGEN
2.63
Q1
2.47
Min
0.10
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Qiagen (QGEN) at 0.47 is near its industry mid-range for debt-to-equity ratio, while IQVIA (IQV) at 2.40 sits above its benchmark range, pointing to a heavier debt load relative to equity.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40

IQV
2.40
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.47

Max
1.42
Q3
0.65
QGEN
0.47
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for IQVIA (IQV) and Qiagen (QGEN)
MetricIQVQGEN
Current Ratio (MRQ)0.832.63
Debt / Equity (MRQ)2.400.47
Net Debt / EBITDA4.461.08

Dividends

Dividend Yield (TTM)

IQVIA (IQV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Qiagen (QGEN) reports a yield of 0.71%, ranking against industry peers normally.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

IQV
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.71%

QGEN
0.71%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

IQVIA (IQV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Qiagen (QGEN) reports a payout of 18.21%, ranking against industry peers normally.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

IQV
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.21%

QGEN
18.21%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for IQVIA (IQV) and Qiagen (QGEN)
MetricIQVQGEN
Dividend Yield (TTM)0.00%0.71%
Dividend Payout Ratio (TTM)0.00%18.21%

Valuation

P/E Ratio (TTM)

Both IQVIA (IQV) at 33.07 and Qiagen (QGEN) at 27.21 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

33.07

Max
85.34
Q3
43.46
IQV
33.07
Median
26.69
Q1
13.30
Min
0.07

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.21

Max
85.34
Q3
43.46
QGEN
27.21
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

IQVIA (IQV) at 2.59 sits in the cheaper P/S ratio quartile while Qiagen (QGEN) at 4.91 prices around its industry’s middle — IQV costs less per dollar of sales, though read it alongside growth and margins.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.59

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
IQV
2.59
Min
0.01

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.91

Max
58.18
Q3
25.77
Median
7.30
QGEN
4.91
Q1
3.01
Min
0.01
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Qiagen (QGEN) at 2.99 is valued about in line with its industry on P/B ratio, while IQVIA (IQV) at 6.73 carries an above-peer premium to book — IQV is pricier on assets.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.73

Max
13.53
IQV
6.73
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.99

Max
13.53
Q3
6.54
Median
3.25
QGEN
2.99
Q1
1.69
Min
-5.59
Loading chart…
IQVIA (IQV) vs. Qiagen (QGEN): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for IQVIA (IQV) and Qiagen (QGEN)
MetricIQVQGEN
P/E Ratio (TTM)33.0727.21
P/S Ratio (TTM)2.594.91
P/B Ratio (MRQ)6.732.99
Free Cash Flow Yield (TTM)4.72%3.62%